↓ Skip to main content

Comparative activity of carbapenem testing (the COMPACT study) in Turkey

Overview of attention for article published in BMC Infectious Diseases, February 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative activity of carbapenem testing (the COMPACT study) in Turkey
Published in
BMC Infectious Diseases, February 2012
DOI 10.1186/1471-2334-12-42
Pubmed ID
Authors

Hakan Leblebicioglu, Nedim Cakir, Mustafa Celen, Halil Kurt, Hakan Baris, Joerg Laeuffer, Turkish COMPACT Study Group

Abstract

Recent evidence indicates that Gram-negative bacterial pathogens, the most common of which are Pseudomonas spp., Enterobacteriaceae, and Acinetobacter baumannii, are frequent causes of hospital-acquired infections. This study aims to evaluate the in vitro activity of doripenem and comparator carbapenem antibiotics against Gram-negative clinical isolates collected from COMParative Activity of Carbapenem Testing (COMPACT) study centres in Turkey.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 18%
Researcher 4 10%
Student > Ph. D. Student 4 10%
Student > Bachelor 3 8%
Other 3 8%
Other 7 18%
Unknown 12 30%
Readers by discipline Count As %
Medicine and Dentistry 14 35%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Nursing and Health Professions 2 5%
Immunology and Microbiology 2 5%
Agricultural and Biological Sciences 1 3%
Other 2 5%
Unknown 15 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2012.
All research outputs
#18,304,874
of 22,663,150 outputs
Outputs from BMC Infectious Diseases
#5,552
of 7,635 outputs
Outputs of similar age
#120,642
of 155,000 outputs
Outputs of similar age from BMC Infectious Diseases
#55
of 76 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,635 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,000 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.